| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3924604
[patent_doc_number] => 05945407
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Methods and compositions using butyrate esters of threitol'
[patent_app_type] => 1
[patent_app_number] => 9/015811
[patent_app_country] => US
[patent_app_date] => 1998-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4307
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945407.pdf
[firstpage_image] =>[orig_patent_app_number] => 015811
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/015811 | Methods and compositions using butyrate esters of threitol | Jan 28, 1998 | Issued |
Array
(
[id] => 4126836
[patent_doc_number] => 06127350
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-03
[patent_title] => 'Use of phenol substituted diphosphonates as antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/011247
[patent_app_country] => US
[patent_app_date] => 1998-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8051
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/127/06127350.pdf
[firstpage_image] =>[orig_patent_app_number] => 011247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/011247 | Use of phenol substituted diphosphonates as antineoplastic agents | Jan 27, 1998 | Issued |
Array
(
[id] => 4115610
[patent_doc_number] => 06046199
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/007098
[patent_app_country] => US
[patent_app_date] => 1998-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4774
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046199.pdf
[firstpage_image] =>[orig_patent_app_number] => 007098
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/007098 | Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives | Jan 13, 1998 | Issued |
Array
(
[id] => 4031584
[patent_doc_number] => 05994328
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Hypoestoxides, derivatives and agonists thereof for use as anticancer agents'
[patent_app_type] => 1
[patent_app_number] => 9/006946
[patent_app_country] => US
[patent_app_date] => 1998-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 5456
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994328.pdf
[firstpage_image] =>[orig_patent_app_number] => 006946
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/006946 | Hypoestoxides, derivatives and agonists thereof for use as anticancer agents | Jan 13, 1998 | Issued |
Array
(
[id] => 4179638
[patent_doc_number] => 06037345
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/005731
[patent_app_country] => US
[patent_app_date] => 1998-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6453
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037345.pdf
[firstpage_image] =>[orig_patent_app_number] => 005731
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/005731 | Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives | Jan 12, 1998 | Issued |
| 08/945365 | COMPOSITION COMPRISING AMOXYCILLIN AND CLAVULANIC ACID | Jan 8, 1998 | Abandoned |
Array
(
[id] => 4066571
[patent_doc_number] => 06008260
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'Cancer chemopreventative composition and method'
[patent_app_type] => 1
[patent_app_number] => 9/005114
[patent_app_country] => US
[patent_app_date] => 1998-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 4567
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/008/06008260.pdf
[firstpage_image] =>[orig_patent_app_number] => 005114
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/005114 | Cancer chemopreventative composition and method | Jan 8, 1998 | Issued |
Array
(
[id] => 3997528
[patent_doc_number] => 05922714
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Combination of MDAM and 5-fluoropyrimidines for treating cancer'
[patent_app_type] => 1
[patent_app_number] => 8/996540
[patent_app_country] => US
[patent_app_date] => 1997-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3927
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922714.pdf
[firstpage_image] =>[orig_patent_app_number] => 996540
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/996540 | Combination of MDAM and 5-fluoropyrimidines for treating cancer | Dec 22, 1997 | Issued |
| 08/996027 | METHOD FOR TREATING PROLIFERATIVE DISEASE | Dec 21, 1997 | Abandoned |
| 08/993898 | PHARMACEUTICAL FORMULATIONS COMPRISING CLAVULANIC ACID ALONE OR IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS | Dec 17, 1997 | Abandoned |
Array
(
[id] => 3762368
[patent_doc_number] => 05852035
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines'
[patent_app_type] => 1
[patent_app_number] => 8/989357
[patent_app_country] => US
[patent_app_date] => 1997-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9688
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852035.pdf
[firstpage_image] =>[orig_patent_app_number] => 989357
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/989357 | Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines | Dec 11, 1997 | Issued |
Array
(
[id] => 4082056
[patent_doc_number] => 06054437
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Method for inducing death of neoplastic cells using piperazine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/988056
[patent_app_country] => US
[patent_app_date] => 1997-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 11404
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054437.pdf
[firstpage_image] =>[orig_patent_app_number] => 988056
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/988056 | Method for inducing death of neoplastic cells using piperazine derivatives | Dec 9, 1997 | Issued |
Array
(
[id] => 4003233
[patent_doc_number] => 05859013
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Method for inducing death of neoplastic cells using piperazine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/987816
[patent_app_country] => US
[patent_app_date] => 1997-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 39
[patent_no_of_words] => 11399
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859013.pdf
[firstpage_image] =>[orig_patent_app_number] => 987816
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/987816 | Method for inducing death of neoplastic cells using piperazine derivatives | Dec 9, 1997 | Issued |
Array
(
[id] => 4149038
[patent_doc_number] => 06103231
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Antibiotic stalobacins'
[patent_app_type] => 1
[patent_app_number] => 8/890756
[patent_app_country] => US
[patent_app_date] => 1997-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7745
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103231.pdf
[firstpage_image] =>[orig_patent_app_number] => 890756
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/890756 | Antibiotic stalobacins | Dec 8, 1997 | Issued |
Array
(
[id] => 4187135
[patent_doc_number] => 06093704
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Use of dopamine receptor antagonists in palliative tumor therapy'
[patent_app_type] => 1
[patent_app_number] => 8/986235
[patent_app_country] => US
[patent_app_date] => 1997-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 1478
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093704.pdf
[firstpage_image] =>[orig_patent_app_number] => 986235
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/986235 | Use of dopamine receptor antagonists in palliative tumor therapy | Dec 4, 1997 | Issued |
| 08/985705 | USE OF EQUILENIN AS AN ANTIOXIDANT | Dec 4, 1997 | Abandoned |
| 08/985795 | USE OF 17 ALPHA -DIHYDROEQUILENIN AS AN ANTIOXIDANT | Dec 4, 1997 | Abandoned |
Array
(
[id] => 1356380
[patent_doc_number] => 06576659
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-10
[patent_title] => 'Use of oxandrolone in the treatment of burns an other wounds'
[patent_app_type] => B1
[patent_app_number] => 08/985734
[patent_app_country] => US
[patent_app_date] => 1997-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4535
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576659.pdf
[firstpage_image] =>[orig_patent_app_number] => 08985734
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/985734 | Use of oxandrolone in the treatment of burns an other wounds | Dec 4, 1997 | Issued |
Array
(
[id] => 3997995
[patent_doc_number] => 05922747
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Indole derivatives as steroid 5.alpha.-reductase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/982735
[patent_app_country] => US
[patent_app_date] => 1997-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10943
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922747.pdf
[firstpage_image] =>[orig_patent_app_number] => 982735
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/982735 | Indole derivatives as steroid 5.alpha.-reductase inhibitors | Dec 1, 1997 | Issued |
Array
(
[id] => 3987746
[patent_doc_number] => 05910505
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => 'Leukotriene antagonists for use in the treatment or inhibition of oral squamous cell carcinoma'
[patent_app_type] => 1
[patent_app_number] => 8/982601
[patent_app_country] => US
[patent_app_date] => 1997-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8638
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 533
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910505.pdf
[firstpage_image] =>[orig_patent_app_number] => 982601
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/982601 | Leukotriene antagonists for use in the treatment or inhibition of oral squamous cell carcinoma | Dec 1, 1997 | Issued |